Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
about
Circovirus transport proceeds via direct interaction of the cytoplasmic dynein IC1 subunit with the viral capsid proteinBit by bit: using design-based research to improve the health literacy of adolescentsXenotransplantation - A special case of One HealthDevelopment of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencingCharacterization of an Sf-rhabdovirus-negative Spodoptera frugiperda cell line as an alternative host for recombinant protein production in the baculovirus-insect cell system.Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisSerologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis.Porcine Circoviruses and Xenotransplantation.The porcine virome and xenotransplantation.Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection.Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.Caspase-Dependent Apoptosis Induction via Viral Protein ORF4 of Porcine Circovirus 2 Binding to Mitochondrial Adenine Nucleotide Translocase 3.Possible risks posed by single-stranded DNA viruses of pigs associated with xenotransplantationBreed Differences in PCV2 Uptake and Disintegration in Porcine MonocytesCurrent Perspectives on High-Throughput Sequencing (HTS) for Adventitious Virus Detection: Upstream Sample Processing and Library Preparation
P2860
Q24311598-CB63F9D0-A240-44CD-96EF-4DAC30E535A4Q28634362-A1118B91-6EB8-4D00-B5B1-2A546FFE0249Q33753481-45838FD2-1A1C-4801-9176-ADEC12A6200CQ36772744-52D94FD1-5612-42BE-AAA1-D286A3C881D4Q36828495-E0A72BA5-37CB-49E9-80E5-CE919940A60BQ37458983-B282E2D8-4293-4194-AC88-A3215AE0EDE0Q37619157-884A9CF5-0D14-411C-8DEB-2013BB8B89CDQ39251840-D20B1D48-4E67-4CDC-A746-927ADC15E22FQ40057091-40B81850-20AB-4B89-BD66-DE76FD0C9D25Q40693674-4536D39B-48EC-4F64-B96F-CB7FCB671296Q41110558-6A27351A-E9EA-4F84-95FD-A601622C6CE9Q47574011-B1A04B2B-F174-43F2-B28C-27ACF999D0E5Q52680813-0BAD70CC-1DA8-4536-AA2C-92343A414655Q56997423-367105E5-01D5-4189-B1FE-428D1F16C1A3Q57466486-B2B6CA6F-9ADA-4356-8615-19437F22F6C9Q58559700-47E102E9-4B4F-48FE-9707-7356B3B11F01
P2860
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Investigation of a regulatory ...... Rotarix: approach and outcome.
@en
Investigation of a regulatory ...... Rotarix: approach and outcome.
@nl
type
label
Investigation of a regulatory ...... Rotarix: approach and outcome.
@en
Investigation of a regulatory ...... Rotarix: approach and outcome.
@nl
prefLabel
Investigation of a regulatory ...... Rotarix: approach and outcome.
@en
Investigation of a regulatory ...... Rotarix: approach and outcome.
@nl
P2093
P2860
P356
P1476
Investigation of a regulatory ...... Rotarix: approach and outcome
@en
P2093
Barbara Howe
Donna Boyce
Gary Dubin
Htay Htay Han
Jean-Pol Cassart
Leonard Friedland
Remon Abu-Elyazeed
Serge Debrus
Sylviane Poncelet
P2860
P304
P356
10.4161/HV.25973
P577
2013-08-28T00:00:00Z